Similar articles for PMID: 29633495

Year	Number of Results
1963	1
1976	1
1977	2
1978	2
1979	2
1981	1
1983	3
1984	1
1985	1
1986	2
1988	2
1989	1
1992	1
1994	1
1996	1
2000	1
2001	1
2002	1
2003	2
2005	3
2006	1
2007	4
2008	3
2009	3
2010	5
2011	3
2012	1
2013	4
2014	5
2015	7
2016	3
2017	7
2018	5
2019	4
2020	7
2021	3
2022	10
2023	5
2024	0

1

Mechanisms of enhanced thrombin-generating capacity in patients with cirrhosis.

Lisman T, Bos S, Intagliata NM. Lisman T, et al. J Thromb Haemost. 2018 Jun;16(6):1128-1131. doi: 10.1111/jth.14020. Epub 2018 May 17. J Thromb Haemost. 2018. PMID: 29633495 Free article. No abstract available.

2

Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.

Sinegre T, Duron C, Lecompte T, Pereira B, Massoulier S, Lamblin G, Abergel A, Lebreton A. Sinegre T, et al. J Thromb Haemost. 2018 Jun;16(6):1132-1140. doi: 10.1111/jth.14011. Epub 2018 May 17. J Thromb Haemost. 2018. PMID: 29577605 Free article.

3

Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.

Scheiner B, Balcar L, Nussbaumer RJ, Weinzierl J, Paternostro R, Simbrunner B, Hartl L, Jachs M, Bauer D, Stättermayer AF, Semmler G, Pinter M, Ay C, Quehenberger P, Trauner M, Reiberger T, Lisman T, Mandorfer M. Scheiner B, et al. J Hepatol. 2022 May;76(5):1090-1099. doi: 10.1016/j.jhep.2021.12.038. Epub 2022 Jan 20. J Hepatol. 2022. PMID: 35066090 Free article.

4

An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.

Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, de Franchis R, Colombo M, Mannucci PM. Tripodi A, et al. Gastroenterology. 2009 Dec;137(6):2105-11. doi: 10.1053/j.gastro.2009.08.045. Epub 2009 Aug 23. Gastroenterology. 2009. PMID: 19706293

5

Intraindividual variability over time of thrombin generation in patients with cirrhosis.

Sinegre T, Duron C, Lecompte T, Lamblin G, Talon L, Muti L, Massoulier S, Pereira B, Lebreton A, Abergel A. Sinegre T, et al. J Thromb Haemost. 2023 Jun;21(6):1441-1452. doi: 10.1016/j.jtha.2023.02.002. Epub 2023 Feb 8. J Thromb Haemost. 2023. PMID: 36758726

6

HEPARIN TREATMENT OF BLEEDING DUE TO PRIMARY HYPERCOAGULABILITY.

VONFRANCKEN I, JOHANSSON L, OLSSON PI, ZETTERQVIST E. VONFRANCKEN I, et al. J Cardiovasc Surg (Torino). 1963 Aug;4:650-2. J Cardiovasc Surg (Torino). 1963. PMID: 14058386 No abstract available.

7

Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.

Lebreton A, Sinegre T, Pereira B, Lamblin G, Duron C, Abergel A. Lebreton A, et al. J Gastroenterol Hepatol. 2017 Apr;32(4):916-924. doi: 10.1111/jgh.13493. J Gastroenterol Hepatol. 2017. PMID: 27421039

8

Prominent protein Z-induced thrombin inhibition in cirrhosis: a new functional assay for hypercoagulability assessment.

Kim SY, Kim JE, Kim YJ, Han KS, Kim HK. Kim SY, et al. J Gastroenterol Hepatol. 2015 Apr;30(4):784-93. doi: 10.1111/jgh.12800. J Gastroenterol Hepatol. 2015. PMID: 25303721

9

Procoagulant imbalance in patients with non-alcoholic fatty liver disease.

Tripodi A, Fracanzani AL, Primignani M, Chantarangkul V, Clerici M, Mannucci PM, Peyvandi F, Bertelli C, Valenti L, Fargion S. Tripodi A, et al. J Hepatol. 2014 Jul;61(1):148-54. doi: 10.1016/j.jhep.2014.03.013. Epub 2014 Mar 18. J Hepatol. 2014. PMID: 24657400

10

Cirrhosis: What are all those factor VIII and protein C for?

Tripodi A. Tripodi A. J Hepatol. 2022 Sep;77(3):884-885. doi: 10.1016/j.jhep.2022.03.019. Epub 2022 Mar 26. J Hepatol. 2022. PMID: 35351520 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year